-
Something wrong with this record ?
The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma
H. Horka, V. Staudt, M. Klein, C. Taube, S. Reuter, N. Dehzad, JF. Andersen, J. Kopecky, H. Schild, M. Kotsyfakis, M. Hoffmann, B. Gerlitzki, M. Stassen, T. Bopp, E. Schmitt,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1998 to 1 year ago
Freely Accessible Science Journals
from 1998-01-01 to 1 year ago
Open Access Digital Library
from 1998-01-01
- MeSH
- Asthma immunology metabolism prevention & control MeSH
- Cystatins immunology pharmacology MeSH
- Cytokines immunology metabolism MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Interleukin-9 biosynthesis immunology MeSH
- Ixodidae immunology MeSH
- Real-Time Polymerase Chain Reaction MeSH
- Disease Models, Animal MeSH
- Mice, Inbred BALB C MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- Flow Cytometry MeSH
- Cell Separation MeSH
- T-Lymphocyte Subsets immunology metabolism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Ticks developed a multitude of different immune evasion strategies to obtain a blood meal. Sialostatin L is an immunosuppressive cysteine protease inhibitor present in the saliva of the hard tick Ixodes scapularis. In this study, we demonstrate that sialostatin L strongly inhibits the production of IL-9 by Th9 cells. Because we could show recently that Th9-derived IL-9 is essentially involved in the induction of asthma symptoms, sialostatin L was used for the treatment of experimental asthma. Application of sialostatin L in a model of experimental asthma almost completely abrogated airway hyperresponsiveness and eosinophilia. Our data suggest that sialostatin L can prevent experimental asthma, most likely by inhibiting the IL-9 production of Th9 cells. Thus, alternative to IL-9 neutralization sialostatin L provides the basis for the development of innovative therapeutic strategies to treat asthma.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024035
- 003
- CZ-PrNML
- 005
- 20121207125510.0
- 007
- ta
- 008
- 120815e20120210xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4049/jimmunol.1100529 $2 doi
- 035 __
- $a (PubMed)22327077
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Horka, Helena $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic and Faculty of Science, University of South Bohemia, 37005 České Budějovice, Czech Republic.
- 245 14
- $a The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma / $c H. Horka, V. Staudt, M. Klein, C. Taube, S. Reuter, N. Dehzad, JF. Andersen, J. Kopecky, H. Schild, M. Kotsyfakis, M. Hoffmann, B. Gerlitzki, M. Stassen, T. Bopp, E. Schmitt,
- 520 9_
- $a Ticks developed a multitude of different immune evasion strategies to obtain a blood meal. Sialostatin L is an immunosuppressive cysteine protease inhibitor present in the saliva of the hard tick Ixodes scapularis. In this study, we demonstrate that sialostatin L strongly inhibits the production of IL-9 by Th9 cells. Because we could show recently that Th9-derived IL-9 is essentially involved in the induction of asthma symptoms, sialostatin L was used for the treatment of experimental asthma. Application of sialostatin L in a model of experimental asthma almost completely abrogated airway hyperresponsiveness and eosinophilia. Our data suggest that sialostatin L can prevent experimental asthma, most likely by inhibiting the IL-9 production of Th9 cells. Thus, alternative to IL-9 neutralization sialostatin L provides the basis for the development of innovative therapeutic strategies to treat asthma.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bronchiální astma $x imunologie $x metabolismus $x prevence a kontrola $7 D001249
- 650 _2
- $a separace buněk $7 D002469
- 650 _2
- $a cystatiny $x imunologie $x farmakologie $7 D015891
- 650 _2
- $a cytokiny $x imunologie $x metabolismus $7 D016207
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a interleukin-9 $x biosyntéza $x imunologie $7 D016906
- 650 _2
- $a Ixodidae $x imunologie $7 D026863
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Staudt, Valérie
- 700 1_
- $a Klein, Matthias
- 700 1_
- $a Taube, Christian
- 700 1_
- $a Reuter, Sebastian
- 700 1_
- $a Dehzad, Nina
- 700 1_
- $a Andersen, John F $7 gn_A_00006077
- 700 1_
- $a Kopecky, Jan
- 700 1_
- $a Schild, Hansjörg
- 700 1_
- $a Kotsyfakis, Michalis
- 700 1_
- $a Hoffmann, Markus
- 700 1_
- $a Gerlitzki, Bastian
- 700 1_
- $a Stassen, Michael
- 700 1_
- $a Bopp, Tobias
- 700 1_
- $a Schmitt, Edgar
- 773 0_
- $w MED00002741 $t Journal of immunology (Baltimore, Md. : 1950) $x 1550-6606 $g Roč. 188, č. 6 (20120210), s. 2669-76
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22327077 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20121207125544 $b ABA008
- 999 __
- $a ok $b bmc $g 946183 $s 781363
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 188 $c 6 $d 2669-76 $e 20120210 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741
- LZP __
- $a Pubmed-20120815/12/02